Abstract
Oct4 is a transcription factor (TF), which works as a transcriptional activator and plays an essential role in reprogramming or direct conversion of somatic cells. Many strategies have been reported to transduce TFs including Oct4 into the cells by delivering the gene; however, the reported methods are associated with several problems such as genetic mutation, cytotoxicity, and low transfection efficiency. Although direct delivery of the transcription factors has been suggested as an alternative method, its use is limited due to poor solubility and stability of recombinant TFs. Previously, it has been reported that the conjugation of Bombyx mori 30Kc19 protein not only facilitates intracellular delivery but also augments soluble expression in Escherichia coli and stability of recombinant TFs. However, the expression levels of the 30Kc19-conjugated TFs were still low. In the present work, we reconstituted 30Kc19-conjugated Oct4 protein (Oct4-30Kc19) expressed as inclusion bodies and compared to soluble expression. The insoluble Oct4-30Kc19 was denatured and refolded in an affinity chromatography column. The refolded Oct4-30Kc19 exhibited cell-penetrating property without any significant cytotoxicity and enhancement in thermal stability similar to soluble Oct4-30Kc19; while a drastic increase in total production yield was observed. In addition, the transcriptional activity of the refolded Oct4-30Kc19 was demonstrated through Oct4-GFP reporter assay. It is anticipated that the refolded Oct4-30Kc19 can be utilized as a valuable tool for transgene-free cellular reprogramming and direct conversion.
Similar content being viewed by others
References
Takahashi, K. and S. Yamanaka (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126: 663–676.
Sterneckert, J., S. Höing, and H. R. Schöler (2012) Concise review: Oct4 and more: the reprogramming expressway. Stem Cells. 30: 15–21.
Esch, D., J. Vahokoski, M. R. Groves, V. Pogenberg, V. Cojocaru, H. Vom Bruch, D. Han, H. C. Drexler, M. J. Araúzo-Bravo, C. K. Ng, R. Jauch, M. Wilmanns, and H. R. Schöler (2013) A unique Oct4 interface is crucial for reprogramming to pluripotency. Nat. Cell Biol. 15: 295–301.
Shi, G. and Y. Jin (2010) Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res. Ther. 1: 39.
Simandi, Z., A. Horvath, L. C. Wright, I. Cuaranta-Monroy, I. De Luca, K. Karolyi, S. Sauer, J. F. Deleuze, L. J. Gudas, S. M. Cowley, and L. Nagy (2016) OCT4 acts as an integrator of pluripotency and signal-induced differentiation. Mol. Cell. 63: 647–661.
Nakagawa, M., M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka, T. Aoi, K. Okita, Y. Mochiduki, N. Takizawa, and S. Yamanaka (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26: 101–106.
Li, W., E. Tian, Z. X. Chen, G. Sun, P. Ye, S. Yang, D. Lu, J. Xie, T. V. Ho, W. M. Tsark, C. Wang, D. A. Horne, A. D. Riggs, M. L. Yip, and Y. Shi (2012) Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proc. Natl. Acad. Sci. USA. 109: 20853–20858.
Kim, J. B., B. Greber, M. J. Araúzo-Bravo, J. Meyer, K. I. Park, H. Zaehres, and H. R. Schöler (2009) Direct reprogramming of human neural stem cells by OCT4. Nature. 461: 649–653.
Thier, M., P. Wörsdörfer, Y. B. Lakes, R. Gorris, S. Herms, T. Opitz, D. Seiferling, T. Quandel, P. Hoffmann, M. M. Nöthen, O. Brüstle, and F. Edenhofer (2012) Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell. 10: 473–479.
Han, D. W., N. Tapia, A. Hermann, K. Hemmer, S. Höing, M. J. Araúzo-Bravo, H. Zaehres, G. Wu, S. Frank, S. Moritz, B. Greber, J. H. Yang, H. T. Lee, J. C. Schwamborn, A. Storch, and H. R. Schöler (2012) Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell. 10: 465–472.
Szabo, E., S. Rampalli, R. M. Risueno, A. Schnerch, R. Mitchell, A. Fiebig-Comyn, M. Levadoux-Martin, and M. Bhatia (2010) Direct conversion of human fibroblasts to multilineage blood progenitors. Nature. 468: 521–526.
Efe, J. A., S. Hilcove, J. Kim, H. Zhou, K. Ouyang, G. Wang, J. Chen, and S. Ding (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 13: 215–222.
Yamamoto, K., T. Kishida, Y. Sato, K. Nishioka, A. Ejima, H. Fujiwara, T. Kubo, T. Yamamoto, N. Kanamura, and O. Mazda (2015) Direct conversion of human fibroblasts into functional osteoblasts by defined factors. Proc. Natl. Acad. Sci. USA. 112: 6152–6157.
González, F., S. Boué, and J. C. Izpisúa Belmonte (2011) Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat. Rev. Genet. 12: 231–242.
Yu, J., K. Hu, K. Smuga-Otto, S. Tian, R. Stewart, I. I. Slukvin, and J. A. Thomson (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science. 324: 797–801.
Woltjen, K., I. P. Michael, P. Mohseni, R. Desai, M. Mileikovsky, R. Hämäläinen, R. Cowling, W. Wang, P. Liu, M. Gertsenstein, K. Kaji, H. K. Sung, and A. Nagy (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 458: 766–770.
Okita, K., Y. Matsumura, Y. Sato, A. Okada, A. Morizane, S. Okamoto, H. Hong, M. Nakagawa, K. Tanabe, K. Tezuka, T. Shibata, T. Kunisad, M. Takahashi, J. Takahashi, H. Saji, and S. Yamanaka (2011) A more efficient method to generate integration-free human iPS cells. Nat. Methods. 8: 409–412.
Warren, L., P. D. Manos, T. Ahfeldt, Y. H. Loh, H. Li, F. Lau, W. Ebina, P. K. Mandal, Z. D. Smith, A. Meissner, G. Q. Daley, A. S. Brack, J. J. Collins, C. Cowan, T. M. Schlaeger, and D. J. Rossi (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 7: 618–630.
Sharei, A., J. Zoldan, A. Adamo, W. Y. Sim, N. Cho, E. Jackson, S. Mao, S. Schneider, M. J. Han, A. Lytton-Jean, P. A. Basto, S. Jhunjhunwala, J. Lee, D. A. Heller, J. W. Kang, G. C. Hartoularos, K. S. Kim, D. G. Anderson, R. Langer, and K. F. Jensen (2013) A vector-free microfluidic platform for intracellular delivery. Proc. Natl. Acad. Sci. USA. 110: 2082–2087.
Cho, H. J., C. S. Lee, Y. W. Kwon, J. S. Paek, S. H. Lee, J. Hur, E. J. Lee, T. Y. Roh, I. S. Chu, S. H. Leem, Y. Kim, H. J. Kang, Y. B. Park, and H. S. Kim (2010) Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation. Blood. 116: 386–395.
Zhou, H., S. Wu, J. Y. Joo, S. Zhu, D. W. Han, T. Lin, S. Trauger, G. Bien, S. Yao, Y. Zhu, G. Siuzdak, H. R. Schöler, L. Duan, and S. Ding (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell. 4: 381–384.
Kim, D., C. H. Kim, J. I. Moon, Y. G. Chung, M. Y. Chang, B. S. Han, S. Ko, E. Yang, K. Y. Cha, R. Lanza, and K. S. Kim (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 4: 472–476.
Zhang, H., Y. Ma, J. Gu, B. Liao, J. Li, J. Wong, and Y. Jin (2012) Reprogramming of somatic cells via TAT-mediated protein transduction of recombinant factors. Biomaterials. 33: 5047–5055.
Lim, J., J. Kim, J. Kang, and D. Jo (2014) Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors. Sci. Rep. 4: 4361.
Park, J. H., J. H. Lee, H. H. Park, W. J. Rhee, S. S. Choi, and T. H. Park (2012) A protein delivery system using 30Kc19 cell-penetrating protein originating from silkworm. Biomaterials. 33: 9127–9134.
Park, H. H., Y. Sohn, J. W. Yeo, J. H. Park, H. J. Lee, J. Ryu, W. J. Rhee, and T. H. Park (2014) Identification and characterization of a novel cell-penetrating peptide of 30Kc19 protein derived from Bombyx mori. Process Biochem. 49: 1516–1526.
Park, J. H., H. H. Park, S. S. Choi, and T. H. Park (2012) Stabilization of enzymes by the recombinant 30Kc19 protein. Process Biochem. 47: 164–169.
Lee, H. J., H. H. Park, J. A. Kim, J. H. Park, J. Ryu, J. Choi, J. Lee, W. J. Rhee, and T. H. Park (2014) Enzyme delivery using the 30Kc19 protein and human serum albumin nanoparticles. Biomaterials. 35: 1696–1704.
Ryu, J., H. H. Park, J. H. Park, H. J. Lee, W. J. Rhee, and T. H. Park (2016) Soluble expression and stability enhancement of transcription factors using 30Kc19 cell-penetrating protein. Appl. Microbiol. Biotechnol. 100: 3523–3532.
Gafni, O., L. Weinberger, A. A. Mansour, Y. S. Manor, E. Chomsky, D. Ben-Yosef, Y. Kalma, S. Viukov, I. Maza, A. Zviran, Y. Rais, Z. Shipony, Z. Mukamel, V. Krupalnik, M. Zerbib, S. Geula, I. Caspi, D. Schneir, T. Shwartz, S. Gilad, D. Amann-Zalcenstein, S. Benjamin, I. Amit, A. Tanay, R. Massarwa, N. Novershtem, and J. H. Hanna (2013) Derivation of novel human ground state naive pluripotent stem cells. Nature. 504: 282–286.
Thier, M., B. Münst, and F. Edenhofer (2010) Exploring refined conditions for reprogramming cells by recombinant Oct4 protein. Int. J. Dev. Biol. 54: 1713–1721.
Han, M. J., H. R. Kim, C. O’Reilly, and C. H. Kim (2017) Purification of functional reprogramming factors in mammalian cell using FLAG-Tag. Biochem. Biophys. Res. Commun. 492: 154–160.
Dai, Y., Y. Guo, C. Wang, Q. Liu, Y. Yang, S. Li, X. Guo, R. Lian, R. Yu, H. Liu, and J. Chen (2014) Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells. PLoS One. 9: e109856.
Acknowledgments
This study was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF- 2017M3A9C6031798) and the Ministry of Education (NRF- 2018R1D1A1B07050422). This study was also supported by 2017 Research Grant from Kangwon National University (No. 520170405).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lee, J., Park, H.H. & Park, J.H. Efficient Production of Cell-permeable Oct4 Protein Using 30Kc19 Protein Originating from Silkworm. Biotechnol Bioproc E 24, 964–971 (2019). https://doi.org/10.1007/s12257-019-0204-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-019-0204-5